ID	Gene Name	Species	GOTERM_BP_DIRECT	GOTERM_CC_DIRECT	GOTERM_MF_DIRECT	KEGG_PATHWAY	OMIM_DISEASE	REACTOME_PATHWAY
ABCF1	ATP binding cassette subfamily F member 1(ABCF1)	Homo sapiens	"GO:0006412~translation,GO:0006413~translational initiation,GO:0006954~inflammatory response,GO:0045727~positive regulation of translation,GO:0055085~transmembrane transport,"	"GO:0005635~nuclear envelope,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005840~ribosome,GO:0016020~membrane,GO:0042788~polysomal ribosome,"	"GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008135~translation factor activity, RNA binding,GO:0008494~translation activator activity,GO:0016887~ATPase activity,GO:0043022~ribosome binding,GO:0044822~poly(A) RNA binding,"			"R-HSA-382556:R-HSA-382556,"
CCL19	C-C motif chemokine ligand 19(CCL19)	Homo sapiens	"GO:0001768~establishment of T cell polarity,GO:0001771~immunological synapse formation,GO:0002407~dendritic cell chemotaxis,GO:0002408~myeloid dendritic cell chemotaxis,GO:0002548~monocyte chemotaxis,GO:0002606~positive regulation of dendritic cell antigen processing and presentation,GO:0006874~cellular calcium ion homeostasis,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007154~cell communication,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007257~activation of JUN kinase activity,GO:0009615~response to virus,GO:0010560~positive regulation of glycoprotein biosynthetic process,GO:0031295~T cell costimulation,GO:0032735~positive regulation of interleukin-12 production,GO:0032760~positive regulation of tumor necrosis factor production,GO:0034695~response to prostaglandin E,GO:0042102~positive regulation of T cell proliferation,GO:0042346~positive regulation of NF-kappaB import into nucleus,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043547~positive regulation of GTPase activity,GO:0043552~positive regulation of phosphatidylinositol 3-kinase activity,GO:0045627~positive regulation of T-helper 1 cell differentiation,GO:0045807~positive regulation of endocytosis,GO:0045860~positive regulation of protein kinase activity,GO:0046330~positive regulation of JNK cascade,GO:0048247~lymphocyte chemotaxis,GO:0048260~positive regulation of receptor-mediated endocytosis,GO:0048469~cell maturation,GO:0050718~positive regulation of interleukin-1 beta secretion,GO:0050921~positive regulation of chemotaxis,GO:0051209~release of sequestered calcium ion into cytosol,GO:0051897~positive regulation of protein kinase B signaling,GO:0060326~cell chemotaxis,GO:0060491~regulation of cell projection assembly,GO:0070098~chemokine-mediated signaling pathway,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0071346~cellular response to interferon-gamma,GO:0071347~cellular response to interleukin-1,GO:0071356~cellular response to tumor necrosis factor,GO:0071731~response to nitric oxide,GO:0072610~interleukin-12 secretion,GO:0090023~positive regulation of neutrophil chemotaxis,GO:0097029~mature conventional dendritic cell differentiation,GO:0098586~cellular response to virus,GO:2000107~negative regulation of leukocyte apoptotic process,GO:2000147~positive regulation of cell motility,GO:2000549~positive regulation of dendritic cell dendrite assembly,"	"GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005622~intracellular,"	"GO:0008009~chemokine activity,GO:0031732~CCR7 chemokine receptor binding,GO:0031735~CCR10 chemokine receptor binding,GO:0042379~chemokine receptor binding,GO:0048020~CCR chemokine receptor binding,"	"hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,hsa04064:NF-kappa B signaling pathway,"		"R-HSA-380108:R-HSA-380108,R-HSA-418594:R-HSA-418594,"
CCL23	C-C motif chemokine ligand 23(CCL23)	Homo sapiens	"GO:0002548~monocyte chemotaxis,GO:0006874~cellular calcium ion homeostasis,GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007267~cell-cell signaling,GO:0008285~negative regulation of cell proliferation,GO:0030593~neutrophil chemotaxis,GO:0043547~positive regulation of GTPase activity,GO:0048247~lymphocyte chemotaxis,GO:0050729~positive regulation of inflammatory response,GO:0070098~chemokine-mediated signaling pathway,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0071346~cellular response to interferon-gamma,GO:0071347~cellular response to interleukin-1,GO:0071356~cellular response to tumor necrosis factor,GO:2001264~negative regulation of C-C chemokine binding,"	"GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005623~cell,"	"GO:0008009~chemokine activity,GO:0008201~heparin binding,GO:0031726~CCR1 chemokine receptor binding,"	"hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,"		"R-HSA-416476:R-HSA-416476,R-HSA-418594:R-HSA-418594,R-HSA-444473:R-HSA-444473,"
CCL28	C-C motif chemokine ligand 28(CCL28)	Homo sapiens	"GO:0001954~positive regulation of cell-matrix adhesion,GO:0006935~chemotaxis,GO:0006955~immune response,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0007584~response to nutrient,GO:0060326~cell chemotaxis,GO:1903237~negative regulation of leukocyte tethering or rolling,"	"GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005623~cell,GO:0070062~extracellular exosome,"	"GO:0005515~protein binding,GO:0008009~chemokine activity,"	"hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,hsa04672:Intestinal immune network for IgA production,"		"R-HSA-380108:R-HSA-380108,R-HSA-418594:R-HSA-418594,"
CCL3	C-C motif chemokine ligand 3(CCL3)	Homo sapiens	"GO:0000165~MAPK cascade,GO:0001649~osteoblast differentiation,GO:0001775~cell activation,GO:0002548~monocyte chemotaxis,GO:0006816~calcium ion transport,GO:0006874~cellular calcium ion homeostasis,GO:0006887~exocytosis,GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007010~cytoskeleton organization,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007267~cell-cell signaling,GO:0007610~behavior,GO:0008360~regulation of cell shape,GO:0009636~response to toxic substance,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0010818~T cell chemotaxis,GO:0014808~release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,GO:0019722~calcium-mediated signaling,GO:0023052~signaling,GO:0030335~positive regulation of cell migration,GO:0030502~negative regulation of bone mineralization,GO:0030593~neutrophil chemotaxis,GO:0031663~lipopolysaccharide-mediated signaling pathway,GO:0032760~positive regulation of tumor necrosis factor production,GO:0043308~eosinophil degranulation,GO:0043491~protein kinase B signaling,GO:0043525~positive regulation of neuron apoptotic process,GO:0043547~positive regulation of GTPase activity,GO:0043615~astrocyte cell migration,GO:0043922~negative regulation by host of viral transcription,GO:0045671~negative regulation of osteoclast differentiation,GO:0048245~eosinophil chemotaxis,GO:0048246~macrophage chemotaxis,GO:0048247~lymphocyte chemotaxis,GO:0050718~positive regulation of interleukin-1 beta secretion,GO:0050729~positive regulation of inflammatory response,GO:0050850~positive regulation of calcium-mediated signaling,GO:0050918~positive chemotaxis,GO:0051897~positive regulation of protein kinase B signaling,GO:0051928~positive regulation of calcium ion transport,GO:0051930~regulation of sensory perception of pain,GO:0060326~cell chemotaxis,GO:0070098~chemokine-mediated signaling pathway,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0070723~response to cholesterol,GO:0071346~cellular response to interferon-gamma,GO:0071347~cellular response to interleukin-1,GO:0071356~cellular response to tumor necrosis factor,GO:0071407~cellular response to organic cyclic compound,GO:0071621~granulocyte chemotaxis,GO:0090280~positive regulation of calcium ion import,GO:2000503~positive regulation of natural killer cell chemotaxis,"	"GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0005829~cytosol,"	"GO:0004672~protein kinase activity,GO:0004698~calcium-dependent protein kinase C activity,GO:0005515~protein binding,GO:0008009~chemokine activity,GO:0016004~phospholipase activator activity,GO:0016301~kinase activity,GO:0031726~CCR1 chemokine receptor binding,GO:0031730~CCR5 chemokine receptor binding,GO:0042056~chemoattractant activity,GO:0042802~identical protein binding,"	"hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,hsa04620:Toll-like receptor signaling pathway,hsa05132:Salmonella infection,hsa05142:Chagas disease (American trypanosomiasis),hsa05323:Rheumatoid arthritis,"	"609423~HIV infection, resistance to,"	"R-HSA-380108:R-HSA-380108,"
CCL4	C-C motif chemokine ligand 4(CCL4)	Homo sapiens	"GO:0002548~monocyte chemotaxis,GO:0006928~movement of cell or subcellular component,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007155~cell adhesion,GO:0007163~establishment or maintenance of cell polarity,GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007267~cell-cell signaling,GO:0009615~response to virus,GO:0009636~response to toxic substance,GO:0030593~neutrophil chemotaxis,GO:0035690~cellular response to drug,GO:0043547~positive regulation of GTPase activity,GO:0043922~negative regulation by host of viral transcription,GO:0050729~positive regulation of inflammatory response,GO:0050850~positive regulation of calcium-mediated signaling,GO:0051928~positive regulation of calcium ion transport,GO:0070098~chemokine-mediated signaling pathway,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0071346~cellular response to interferon-gamma,GO:0071347~cellular response to interleukin-1,GO:0071356~cellular response to tumor necrosis factor,GO:2000503~positive regulation of natural killer cell chemotaxis,"	"GO:0005576~extracellular region,GO:0005615~extracellular space,"	"GO:0005125~cytokine activity,GO:0005515~protein binding,GO:0008009~chemokine activity,GO:0031726~CCR1 chemokine receptor binding,GO:0031730~CCR5 chemokine receptor binding,GO:0042802~identical protein binding,"	"hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,hsa04064:NF-kappa B signaling pathway,hsa04620:Toll-like receptor signaling pathway,hsa04623:Cytosolic DNA-sensing pathway,hsa05132:Salmonella infection,"		"R-HSA-380108:R-HSA-380108,"
CCL7	C-C motif chemokine ligand 7(CCL7)	Homo sapiens	"GO:0002548~monocyte chemotaxis,GO:0006874~cellular calcium ion homeostasis,GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0007010~cytoskeleton organization,GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007267~cell-cell signaling,GO:0008360~regulation of cell shape,GO:0010332~response to gamma radiation,GO:0030335~positive regulation of cell migration,GO:0030593~neutrophil chemotaxis,GO:0043547~positive regulation of GTPase activity,GO:0048245~eosinophil chemotaxis,GO:0050729~positive regulation of inflammatory response,GO:0070098~chemokine-mediated signaling pathway,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0071346~cellular response to interferon-gamma,GO:0071347~cellular response to interleukin-1,GO:0071356~cellular response to tumor necrosis factor,GO:0071361~cellular response to ethanol,GO:2000503~positive regulation of natural killer cell chemotaxis,"	"GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005623~cell,"	"GO:0005515~protein binding,GO:0008009~chemokine activity,GO:0008201~heparin binding,GO:0031726~CCR1 chemokine receptor binding,GO:0031727~CCR2 chemokine receptor binding,"	"hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,"		"R-HSA-380108:R-HSA-380108,"
CXCL8	C-X-C motif chemokine ligand 8(CXCL8)	Homo sapiens	"GO:0001525~angiogenesis,GO:0002237~response to molecule of bacterial origin,GO:0006928~movement of cell or subcellular component,GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007050~cell cycle arrest,GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0008285~negative regulation of cell proliferation,GO:0019722~calcium-mediated signaling,GO:0030155~regulation of cell adhesion,GO:0030593~neutrophil chemotaxis,GO:0031623~receptor internalization,GO:0034976~response to endoplasmic reticulum stress,GO:0035556~intracellular signal transduction,GO:0036499~PERK-mediated unfolded protein response,GO:0042119~neutrophil activation,GO:0044344~cellular response to fibroblast growth factor stimulus,GO:0045091~regulation of single stranded viral RNA replication via double stranded DNA intermediate,GO:0045744~negative regulation of G-protein coupled receptor protein signaling pathway,GO:0045766~positive regulation of angiogenesis,GO:0048566~embryonic digestive tract development,GO:0050930~induction of positive chemotaxis,GO:0070098~chemokine-mediated signaling pathway,GO:0071222~cellular response to lipopolysaccharide,GO:0071347~cellular response to interleukin-1,GO:0071356~cellular response to tumor necrosis factor,GO:0090023~positive regulation of neutrophil chemotaxis,GO:2000535~regulation of entry of bacterium into host cell,"	"GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005622~intracellular,"	"GO:0005153~interleukin-8 receptor binding,GO:0005515~protein binding,GO:0008009~chemokine activity,"	"hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,hsa04064:NF-kappa B signaling pathway,hsa04620:Toll-like receptor signaling pathway,hsa04621:NOD-like receptor signaling pathway,hsa04622:RIG-I-like receptor signaling pathway,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa05120:Epithelial cell signaling in Helicobacter pylori infection,hsa05131:Shigellosis,hsa05132:Salmonella infection,hsa05133:Pertussis,hsa05134:Legionellosis,hsa05142:Chagas disease (American trypanosomiasis),hsa05144:Malaria,hsa05146:Amoebiasis,hsa05160:Hepatitis C,hsa05161:Hepatitis B,hsa05164:Influenza A,hsa05200:Pathways in cancer,hsa05202:Transcriptional misregulation in cancer,hsa05219:Bladder cancer,hsa05323:Rheumatoid arthritis,"		"R-HSA-2559582:R-HSA-2559582,R-HSA-375276:R-HSA-375276,R-HSA-380108:R-HSA-380108,R-HSA-380994:R-HSA-380994,R-HSA-418594:R-HSA-418594,"
CXCL9	C-X-C motif chemokine ligand 9(CXCL9)	Homo sapiens	"GO:0002690~positive regulation of leukocyte chemotaxis,GO:0006935~chemotaxis,GO:0006952~defense response,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0006968~cellular defense response,GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007267~cell-cell signaling,GO:0030816~positive regulation of cAMP metabolic process,GO:0032496~response to lipopolysaccharide,GO:0042127~regulation of cell proliferation,GO:0043950~positive regulation of cAMP-mediated signaling,GO:0045663~positive regulation of myoblast differentiation,GO:0051281~positive regulation of release of sequestered calcium ion into cytosol,GO:0051607~defense response to virus,GO:0060326~cell chemotaxis,GO:0070098~chemokine-mediated signaling pathway,GO:1901741~positive regulation of myoblast fusion,"	"GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0009897~external side of plasma membrane,"	"GO:0005125~cytokine activity,GO:0005515~protein binding,GO:0008009~chemokine activity,GO:0048248~CXCR3 chemokine receptor binding,"	"hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,hsa04620:Toll-like receptor signaling pathway,"		"R-HSA-380108:R-HSA-380108,R-HSA-418594:R-HSA-418594,"
CX3CL1	C-X3-C motif chemokine ligand 1(CX3CL1)	Homo sapiens	"GO:0002523~leukocyte migration involved in inflammatory response,GO:0002548~monocyte chemotaxis,GO:0006935~chemotaxis,GO:0006952~defense response,GO:0006955~immune response,GO:0007155~cell adhesion,GO:0007186~G-protein coupled receptor signaling pathway,GO:0019221~cytokine-mediated signaling pathway,GO:0030336~negative regulation of cell migration,GO:0030593~neutrophil chemotaxis,GO:0030595~leukocyte chemotaxis,GO:0032914~positive regulation of transforming growth factor beta1 production,GO:0033622~integrin activation,GO:0043547~positive regulation of GTPase activity,GO:0045766~positive regulation of angiogenesis,GO:0048246~macrophage chemotaxis,GO:0048247~lymphocyte chemotaxis,GO:0050729~positive regulation of inflammatory response,GO:0050902~leukocyte adhesive activation,GO:0051041~positive regulation of calcium-independent cell-cell adhesion,GO:0060055~angiogenesis involved in wound healing,GO:0060326~cell chemotaxis,GO:0070098~chemokine-mediated signaling pathway,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0071346~cellular response to interferon-gamma,GO:0071347~cellular response to interleukin-1,GO:0071356~cellular response to tumor necrosis factor,GO:2001240~negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,"	"GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0016021~integral component of membrane,"	"GO:0005102~receptor binding,GO:0005178~integrin binding,GO:0005515~protein binding,GO:0008009~chemokine activity,GO:0031737~CX3C chemokine receptor binding,GO:0048020~CCR chemokine receptor binding,"	"hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,hsa04668:TNF signaling pathway,"		"R-HSA-380108:R-HSA-380108,"
KITLG	KIT ligand(KITLG)	Homo sapiens	"GO:0000165~MAPK cascade,GO:0001541~ovarian follicle development,GO:0001755~neural crest cell migration,GO:0002687~positive regulation of leukocyte migration,GO:0002763~positive regulation of myeloid leukocyte differentiation,GO:0007155~cell adhesion,GO:0007165~signal transduction,GO:0008283~cell proliferation,GO:0008584~male gonad development,GO:0014066~regulation of phosphatidylinositol 3-kinase signaling,GO:0033026~negative regulation of mast cell apoptotic process,GO:0035162~embryonic hemopoiesis,GO:0035234~ectopic germ cell programmed cell death,GO:0043406~positive regulation of MAP kinase activity,GO:0043547~positive regulation of GTPase activity,GO:0045636~positive regulation of melanocyte differentiation,GO:0045740~positive regulation of DNA replication,GO:0046579~positive regulation of Ras protein signal transduction,GO:0046854~phosphatidylinositol phosphorylation,GO:0048015~phosphatidylinositol-mediated signaling,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0070668~positive regulation of mast cell proliferation,GO:0097192~extrinsic apoptotic signaling pathway in absence of ligand,GO:1902035~positive regulation of hematopoietic stem cell proliferation,"	"GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0030027~lamellipodium,GO:0030175~filopodium,"	"GO:0005088~Ras guanyl-nucleotide exchange factor activity,GO:0005125~cytokine activity,GO:0005173~stem cell factor receptor binding,GO:0005515~protein binding,GO:0008083~growth factor activity,GO:0046934~phosphatidylinositol-4,5-bisphosphate 3-kinase activity,"	"hsa04014:Ras signaling pathway,hsa04015:Rap1 signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04640:Hematopoietic cell lineage,hsa04916:Melanogenesis,hsa05200:Pathways in cancer,"	"145250~Hyperpigmentation with or without hypopigmentation,611664~Skin/hair/eye pigmentation 7, blond/brown hair,616697~Deafness, congenital, unilateral or asymmetric,"	"R-HSA-1257604:R-HSA-1257604,R-HSA-1433557:R-HSA-1433557,R-HSA-1433559:R-HSA-1433559,R-HSA-2219530:R-HSA-2219530,R-HSA-5673001:R-HSA-5673001,"
S100A12	S100 calcium binding protein A12(S100A12)	Homo sapiens	"GO:0002548~monocyte chemotaxis,GO:0006805~xenobiotic metabolic process,GO:0006954~inflammatory response,GO:0030593~neutrophil chemotaxis,GO:0031640~killing of cells of other organism,GO:0042742~defense response to bacterium,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043406~positive regulation of MAP kinase activity,GO:0045087~innate immune response,GO:0045576~mast cell activation,GO:0050663~cytokine secretion,GO:0050729~positive regulation of inflammatory response,GO:0050832~defense response to fungus,GO:0051092~positive regulation of NF-kappaB transcription factor activity,"	"GO:0005576~extracellular region,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,"	"GO:0005507~copper ion binding,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0050786~RAGE receptor binding,"			"R-HSA-1810476:R-HSA-1810476,R-HSA-3134963:R-HSA-3134963,R-HSA-445989:R-HSA-445989,R-HSA-879415:R-HSA-879415,R-HSA-933542:R-HSA-933542,"
TNFRSF10B	TNF receptor superfamily member 10b(TNFRSF10B)	Homo sapiens	"GO:0006915~apoptotic process,GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007165~signal transduction,GO:0007166~cell surface receptor signaling pathway,GO:0007250~activation of NF-kappaB-inducing kinase activity,GO:0007275~multicellular organism development,GO:0008625~extrinsic apoptotic signaling pathway via death domain receptors,GO:0032496~response to lipopolysaccharide,GO:0033209~tumor necrosis factor-mediated signaling pathway,GO:0034976~response to endoplasmic reticulum stress,GO:0042127~regulation of cell proliferation,GO:0042981~regulation of apoptotic process,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0070059~intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,GO:0071260~cellular response to mechanical stimulus,GO:0097296~activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,GO:1902041~regulation of extrinsic apoptotic signaling pathway via death domain receptors,GO:1902042~negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,"	"GO:0005622~intracellular,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,GO:0016021~integral component of membrane,"	"GO:0004872~receptor activity,GO:0005031~tumor necrosis factor-activated receptor activity,GO:0005515~protein binding,GO:0045569~TRAIL binding,"	"hsa04060:Cytokine-cytokine receptor interaction,hsa04210:Apoptosis,hsa04650:Natural killer cell mediated cytotoxicity,hsa05162:Measles,hsa05164:Influenza A,"	"275355~Squamous cell carcinoma, head and neck,"	"R-HSA-140534:R-HSA-140534,R-HSA-3371378:R-HSA-3371378,R-HSA-5213460:R-HSA-5213460,R-HSA-5218900:R-HSA-5218900,R-HSA-69416:R-HSA-69416,R-HSA-75158:R-HSA-75158,"
TNFRSF9	TNF receptor superfamily member 9(TNFRSF9)	Homo sapiens	"GO:0006915~apoptotic process,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007275~multicellular organism development,GO:0008285~negative regulation of cell proliferation,GO:0008625~extrinsic apoptotic signaling pathway via death domain receptors,GO:0032496~response to lipopolysaccharide,GO:0033209~tumor necrosis factor-mediated signaling pathway,GO:0042981~regulation of apoptotic process,GO:0070207~protein homotrimerization,GO:2001180~negative regulation of interleukin-10 secretion,GO:2001183~negative regulation of interleukin-12 secretion,"	"GO:0005615~extracellular space,GO:0005887~integral component of plasma membrane,GO:0009897~external side of plasma membrane,GO:0016021~integral component of membrane,"	"GO:0004872~receptor activity,GO:0005031~tumor necrosis factor-activated receptor activity,GO:0019955~cytokine binding,"	"hsa04060:Cytokine-cytokine receptor interaction,"		
XPNPEP2	X-prolyl aminopeptidase 2(XPNPEP2)	Homo sapiens	"GO:0006508~proteolysis,"	"GO:0005886~plasma membrane,GO:0016020~membrane,GO:0031225~anchored component of membrane,GO:0070062~extracellular exosome,"	"GO:0004177~aminopeptidase activity,GO:0016787~hydrolase activity,GO:0046872~metal ion binding,GO:0070006~metalloaminopeptidase activity,"	"hsa04974:Protein digestion and absorption,"	"300909~Angioedema induced by ACE inhibitors, susceptibility to,"	
AGER	advanced glycosylation end-product specific receptor(AGER)	Homo sapiens	"GO:0001666~response to hypoxia,GO:0001914~regulation of T cell mediated cytotoxicity,GO:0006954~inflammatory response,GO:0007166~cell surface receptor signaling pathway,GO:0009611~response to wounding,GO:0014002~astrocyte development,GO:0031175~neuron projection development,GO:0032693~negative regulation of interleukin-10 production,GO:0032735~positive regulation of interleukin-12 production,GO:0042104~positive regulation of activated T cell proliferation,GO:0043507~positive regulation of JUN kinase activity,GO:0045087~innate immune response,GO:0050930~induction of positive chemotaxis,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0051101~regulation of DNA binding,GO:0071639~positive regulation of monocyte chemotactic protein-1 production,GO:0072657~protein localization to membrane,GO:1904597~negative regulation of connective tissue replacement involved in inflammatory response wound healing,GO:1904604~negative regulation of advanced glycation end-product receptor activity,GO:2000514~regulation of CD4-positive, alpha-beta T cell activation,GO:2001200~positive regulation of dendritic cell differentiation,"	"GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,"	"GO:0004872~receptor activity,GO:0004888~transmembrane signaling receptor activity,GO:0005515~protein binding,GO:0008201~heparin binding,GO:0042802~identical protein binding,GO:0044548~S100 protein binding,GO:1904599~advanced glycation end-product binding,"			"R-HSA-1810476:R-HSA-1810476,R-HSA-3134963:R-HSA-3134963,R-HSA-445989:R-HSA-445989,R-HSA-879415:R-HSA-879415,R-HSA-933542:R-HSA-933542,"
AFM	afamin(AFM)	Homo sapiens	"GO:0051180~vitamin transport,"	"GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0070062~extracellular exosome,GO:0072562~blood microparticle,"	"GO:0008431~vitamin E binding,"			
ALB	albumin(ALB)	Homo sapiens	"GO:0001895~retina homeostasis,GO:0002576~platelet degranulation,GO:0006810~transport,GO:0006898~receptor-mediated endocytosis,GO:0009267~cellular response to starvation,GO:0015721~bile acid and bile salt transport,GO:0019836~hemolysis by symbiont of host erythrocytes,GO:0042157~lipoprotein metabolic process,GO:0043066~negative regulation of apoptotic process,GO:0043069~negative regulation of programmed cell death,GO:0043252~sodium-independent organic anion transport,GO:0051659~maintenance of mitochondrion location,GO:0098869~cellular oxidant detoxification,"	"GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005783~endoplasmic reticulum,GO:0005794~Golgi apparatus,GO:0031093~platelet alpha granule lumen,GO:0043209~myelin sheath,GO:0043234~protein complex,GO:0070062~extracellular exosome,GO:0072562~blood microparticle,"	"GO:0003677~DNA binding,GO:0005504~fatty acid binding,GO:0005507~copper ion binding,GO:0005515~protein binding,GO:0008144~drug binding,GO:0015643~toxic substance binding,GO:0016209~antioxidant activity,GO:0019825~oxygen binding,GO:0030170~pyridoxal phosphate binding,GO:0042802~identical protein binding,GO:0051087~chaperone binding,"		"615999~Dysalbuminemic hyperthyroxinemia,616000~Analbuminemia,"	"R-HSA-114608:R-HSA-114608,R-HSA-159418:R-HSA-159418,R-HSA-194223:R-HSA-194223,R-HSA-2168880:R-HSA-2168880,R-HSA-5619058:R-HSA-5619058,R-HSA-5619110:R-HSA-5619110,R-HSA-879518:R-HSA-879518,"
AHSG	alpha 2-HS glycoprotein(AHSG)	Homo sapiens	"GO:0001501~skeletal system development,GO:0001503~ossification,GO:0002576~platelet degranulation,GO:0006907~pinocytosis,GO:0006953~acute-phase response,GO:0010951~negative regulation of endopeptidase activity,GO:0030500~regulation of bone mineralization,GO:0030502~negative regulation of bone mineralization,GO:0042326~negative regulation of phosphorylation,GO:0046627~negative regulation of insulin receptor signaling pathway,GO:0050727~regulation of inflammatory response,GO:0050766~positive regulation of phagocytosis,GO:0070168~negative regulation of biomineral tissue development,"	"GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0031012~extracellular matrix,GO:0031093~platelet alpha granule lumen,GO:0070062~extracellular exosome,GO:0072562~blood microparticle,"	"GO:0004866~endopeptidase inhibitor activity,GO:0004869~cysteine-type endopeptidase inhibitor activity,GO:0019210~kinase inhibitor activity,"			"R-HSA-114608:R-HSA-114608,"
AZGP1	"alpha-2-glycoprotein 1, zinc-binding(AZGP1)"	Homo sapiens	"GO:0001580~detection of chemical stimulus involved in sensory perception of bitter taste,GO:0001895~retina homeostasis,GO:0007155~cell adhesion,GO:0008285~negative regulation of cell proliferation,GO:0019882~antigen processing and presentation,GO:0055085~transmembrane transport,GO:0071806~protein transmembrane transport,GO:0090501~RNA phosphodiester bond hydrolysis,"	"GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005886~plasma membrane,GO:0070062~extracellular exosome,"	"GO:0001948~glycoprotein binding,GO:0003823~antigen binding,GO:0004540~ribonuclease activity,GO:0005515~protein binding,GO:0008320~protein transmembrane transporter activity,"			"R-HSA-5223345:R-HSA-5223345,"
APOA2	apolipoprotein A2(APOA2)	Homo sapiens	"GO:0001523~retinoid metabolic process,GO:0002526~acute inflammatory response,GO:0002740~negative regulation of cytokine secretion involved in immune response,GO:0006641~triglyceride metabolic process,GO:0006656~phosphatidylcholine biosynthetic process,GO:0006869~lipid transport,GO:0008203~cholesterol metabolic process,GO:0009395~phospholipid catabolic process,GO:0009749~response to glucose,GO:0010873~positive regulation of cholesterol esterification,GO:0010903~negative regulation of very-low-density lipoprotein particle remodeling,GO:0016032~viral process,GO:0018158~protein oxidation,GO:0018206~peptidyl-methionine modification,GO:0030300~regulation of intestinal cholesterol absorption,GO:0031100~organ regeneration,GO:0031647~regulation of protein stability,GO:0032375~negative regulation of cholesterol transport,GO:0033344~cholesterol efflux,GO:0033700~phospholipid efflux,GO:0034370~triglyceride-rich lipoprotein particle remodeling,GO:0034374~low-density lipoprotein particle remodeling,GO:0034375~high-density lipoprotein particle remodeling,GO:0034380~high-density lipoprotein particle assembly,GO:0034384~high-density lipoprotein particle clearance,GO:0042157~lipoprotein metabolic process,GO:0042158~lipoprotein biosynthetic process,GO:0042493~response to drug,GO:0042632~cholesterol homeostasis,GO:0043085~positive regulation of catalytic activity,GO:0043627~response to estrogen,GO:0043691~reverse cholesterol transport,GO:0045416~positive regulation of interleukin-8 biosynthetic process,GO:0046340~diacylglycerol catabolic process,GO:0050995~negative regulation of lipid catabolic process,GO:0050996~positive regulation of lipid catabolic process,GO:0051384~response to glucocorticoid,GO:0060192~negative regulation of lipase activity,GO:0060621~negative regulation of cholesterol import,GO:0060695~negative regulation of cholesterol transporter activity,"	"GO:0005576~extracellular region,GO:0005769~early endosome,GO:0005788~endoplasmic reticulum lumen,GO:0005829~cytosol,GO:0034361~very-low-density lipoprotein particle,GO:0034364~high-density lipoprotein particle,GO:0034366~spherical high-density lipoprotein particle,GO:0042627~chylomicron,GO:0070062~extracellular exosome,GO:0072562~blood microparticle,"	"GO:0005319~lipid transporter activity,GO:0005515~protein binding,GO:0005543~phospholipid binding,GO:0008035~high-density lipoprotein particle binding,GO:0008289~lipid binding,GO:0015485~cholesterol binding,GO:0017127~cholesterol transporter activity,GO:0031210~phosphatidylcholine binding,GO:0034190~apolipoprotein receptor binding,GO:0042803~protein homodimerization activity,GO:0046982~protein heterodimerization activity,GO:0055102~lipase inhibitor activity,GO:0060228~phosphatidylcholine-sterol O-acyltransferase activator activity,GO:0070653~high-density lipoprotein particle receptor binding,"	"hsa03320:PPAR signaling pathway,"	"143890~Hypercholesterolemia, familial, modifier of,Apolipoprotein A-II deficiency~Apolipoprotein A-II deficiency,"	"R-HSA-174800:R-HSA-174800,R-HSA-1989781:R-HSA-1989781,R-HSA-975634:R-HSA-975634,"
APOA4	apolipoprotein A4(APOA4)	Homo sapiens	"GO:0001523~retinoid metabolic process,GO:0002227~innate immune response in mucosa,GO:0006695~cholesterol biosynthetic process,GO:0006869~lipid transport,GO:0006982~response to lipid hydroperoxide,GO:0007159~leukocyte cell-cell adhesion,GO:0008203~cholesterol metabolic process,GO:0010873~positive regulation of cholesterol esterification,GO:0010898~positive regulation of triglyceride catabolic process,GO:0019430~removal of superoxide radicals,GO:0030300~regulation of intestinal cholesterol absorption,GO:0031102~neuron projection regeneration,GO:0032374~regulation of cholesterol transport,GO:0033344~cholesterol efflux,GO:0033700~phospholipid efflux,GO:0034371~chylomicron remodeling,GO:0034372~very-low-density lipoprotein particle remodeling,GO:0034375~high-density lipoprotein particle remodeling,GO:0034378~chylomicron assembly,GO:0034380~high-density lipoprotein particle assembly,GO:0034445~negative regulation of plasma lipoprotein particle oxidation,GO:0035634~response to stilbenoid,GO:0042157~lipoprotein metabolic process,GO:0042158~lipoprotein biosynthetic process,GO:0042632~cholesterol homeostasis,GO:0042744~hydrogen peroxide catabolic process,GO:0043691~reverse cholesterol transport,GO:0044240~multicellular organism lipid catabolic process,GO:0044267~cellular protein metabolic process,GO:0045723~positive regulation of fatty acid biosynthetic process,GO:0046470~phosphatidylcholine metabolic process,GO:0051006~positive regulation of lipoprotein lipase activity,GO:0055088~lipid homeostasis,GO:0065005~protein-lipid complex assembly,GO:0070328~triglyceride homeostasis,"	"GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005769~early endosome,GO:0005788~endoplasmic reticulum lumen,GO:0005829~cytosol,GO:0009986~cell surface,GO:0034361~very-low-density lipoprotein particle,GO:0034364~high-density lipoprotein particle,GO:0042627~chylomicron,GO:0070062~extracellular exosome,GO:0072562~blood microparticle,"	"GO:0005319~lipid transporter activity,GO:0005507~copper ion binding,GO:0005515~protein binding,GO:0008289~lipid binding,GO:0015485~cholesterol binding,GO:0016209~antioxidant activity,GO:0017127~cholesterol transporter activity,GO:0031210~phosphatidylcholine binding,GO:0042803~protein homodimerization activity,GO:0060228~phosphatidylcholine-sterol O-acyltransferase activator activity,"	"hsa04975:Fat digestion and absorption,hsa04977:Vitamin digestion and absorption,"		"R-HSA-174800:R-HSA-174800,R-HSA-975634:R-HSA-975634,R-HSA-977225:R-HSA-977225,"
APOC2	apolipoprotein C2(APOC2)	Homo sapiens	"GO:0001523~retinoid metabolic process,GO:0006629~lipid metabolic process,GO:0006869~lipid transport,GO:0010518~positive regulation of phospholipase activity,GO:0010898~positive regulation of triglyceride catabolic process,GO:0010902~positive regulation of very-low-density lipoprotein particle remodeling,GO:0010916~negative regulation of very-low-density lipoprotein particle clearance,GO:0016042~lipid catabolic process,GO:0032375~negative regulation of cholesterol transport,GO:0033344~cholesterol efflux,GO:0033700~phospholipid efflux,GO:0034370~triglyceride-rich lipoprotein particle remodeling,GO:0034371~chylomicron remodeling,GO:0034372~very-low-density lipoprotein particle remodeling,GO:0034382~chylomicron remnant clearance,GO:0034384~high-density lipoprotein particle clearance,GO:0042157~lipoprotein metabolic process,GO:0042632~cholesterol homeostasis,GO:0043086~negative regulation of catalytic activity,GO:0043691~reverse cholesterol transport,GO:0045723~positive regulation of fatty acid biosynthetic process,GO:0045833~negative regulation of lipid metabolic process,GO:0048261~negative regulation of receptor-mediated endocytosis,GO:0051006~positive regulation of lipoprotein lipase activity,GO:0060697~positive regulation of phospholipid catabolic process,GO:0070328~triglyceride homeostasis,"	"GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005769~early endosome,GO:0034361~very-low-density lipoprotein particle,GO:0034362~low-density lipoprotein particle,GO:0034363~intermediate-density lipoprotein particle,GO:0034366~spherical high-density lipoprotein particle,GO:0042627~chylomicron,GO:0070062~extracellular exosome,"	"GO:0008047~enzyme activator activity,GO:0008289~lipid binding,GO:0016004~phospholipase activator activity,GO:0042803~protein homodimerization activity,GO:0043274~phospholipase binding,GO:0055102~lipase inhibitor activity,GO:0060230~lipoprotein lipase activator activity,"		"207750~Hyperlipoproteinemia, type Ib,"	"R-HSA-174800:R-HSA-174800,R-HSA-194223:R-HSA-194223,R-HSA-975634:R-HSA-975634,"
APOC3	apolipoprotein C3(APOC3)	Homo sapiens	"GO:0001523~retinoid metabolic process,GO:0006641~triglyceride metabolic process,GO:0006869~lipid transport,GO:0007186~G-protein coupled receptor signaling pathway,GO:0010897~negative regulation of triglyceride catabolic process,GO:0010903~negative regulation of very-low-density lipoprotein particle remodeling,GO:0010916~negative regulation of very-low-density lipoprotein particle clearance,GO:0010987~negative regulation of high-density lipoprotein particle clearance,GO:0010989~negative regulation of low-density lipoprotein particle clearance,GO:0019433~triglyceride catabolic process,GO:0032489~regulation of Cdc42 protein signal transduction,GO:0033344~cholesterol efflux,GO:0033700~phospholipid efflux,GO:0034375~high-density lipoprotein particle remodeling,GO:0034379~very-low-density lipoprotein particle assembly,GO:0034382~chylomicron remnant clearance,GO:0042157~lipoprotein metabolic process,GO:0042632~cholesterol homeostasis,GO:0043691~reverse cholesterol transport,GO:0045717~negative regulation of fatty acid biosynthetic process,GO:0045833~negative regulation of lipid metabolic process,GO:0048261~negative regulation of receptor-mediated endocytosis,GO:0050995~negative regulation of lipid catabolic process,GO:0051005~negative regulation of lipoprotein lipase activity,GO:0060621~negative regulation of cholesterol import,GO:0070328~triglyceride homeostasis,"	"GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005769~early endosome,GO:0034361~very-low-density lipoprotein particle,GO:0034363~intermediate-density lipoprotein particle,GO:0034366~spherical high-density lipoprotein particle,GO:0042627~chylomicron,GO:0070062~extracellular exosome,"	"GO:0005543~phospholipid binding,GO:0008289~lipid binding,GO:0015485~cholesterol binding,GO:0030234~enzyme regulator activity,GO:0055102~lipase inhibitor activity,GO:0070653~high-density lipoprotein particle receptor binding,"	"hsa03320:PPAR signaling pathway,"	"614028~Apolipoprotein C-III deficiency,"	"R-HSA-174800:R-HSA-174800,R-HSA-194223:R-HSA-194223,R-HSA-975634:R-HSA-975634,"
APOD	apolipoprotein D(APOD)	Homo sapiens	"GO:0000302~response to reactive oxygen species,GO:0001525~angiogenesis,GO:0006006~glucose metabolic process,GO:0006629~lipid metabolic process,GO:0006869~lipid transport,GO:0007420~brain development,GO:0007568~aging,GO:0010642~negative regulation of platelet-derived growth factor receptor signaling pathway,GO:0014012~peripheral nervous system axon regeneration,GO:0042246~tissue regeneration,GO:0042308~negative regulation of protein import into nucleus,GO:0042493~response to drug,GO:0048662~negative regulation of smooth muscle cell proliferation,GO:0048678~response to axon injury,GO:0051895~negative regulation of focal adhesion assembly,GO:0060588~negative regulation of lipoprotein lipid oxidation,GO:0071638~negative regulation of monocyte chemotactic protein-1 production,GO:1900016~negative regulation of cytokine production involved in inflammatory response,GO:2000098~negative regulation of smooth muscle cell-matrix adhesion,GO:2000405~negative regulation of T cell migration,"	"GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005783~endoplasmic reticulum,GO:0022626~cytosolic ribosome,GO:0030425~dendrite,GO:0043025~neuronal cell body,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,"	"GO:0005215~transporter activity,GO:0005319~lipid transporter activity,GO:0005515~protein binding,GO:0008289~lipid binding,GO:0015485~cholesterol binding,GO:0036094~small molecule binding,"			"R-HSA-804914:R-HSA-804914,"
APOL1	apolipoprotein L1(APOL1)	Homo sapiens	"GO:0006869~lipid transport,GO:0006898~receptor-mediated endocytosis,GO:0008203~cholesterol metabolic process,GO:0019835~cytolysis,GO:0031640~killing of cells of other organism,GO:0042157~lipoprotein metabolic process,GO:0045087~innate immune response,GO:1902476~chloride transmembrane transport,"	"GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0016021~integral component of membrane,GO:0031224~intrinsic component of membrane,GO:0034361~very-low-density lipoprotein particle,GO:0034364~high-density lipoprotein particle,GO:0072562~blood microparticle,"	"GO:0005254~chloride channel activity,GO:0005515~protein binding,GO:0008289~lipid binding,"		"612551~End-stage renal disease, nondiabetic, susceptibility to,612551~Glomerulosclerosis, focal segmental, 4, susceptibility to,"	"R-HSA-2168880:R-HSA-2168880,"
CTSD	cathepsin D(CTSD)	Homo sapiens	"GO:0006508~proteolysis,GO:0006914~autophagy,GO:0019886~antigen processing and presentation of exogenous peptide antigen via MHC class II,GO:0030163~protein catabolic process,GO:0030574~collagen catabolic process,"	"GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005764~lysosome,GO:0031012~extracellular matrix,GO:0042470~melanosome,GO:0043202~lysosomal lumen,GO:0045121~membrane raft,GO:0070062~extracellular exosome,"	"GO:0004190~aspartic-type endopeptidase activity,GO:0004197~cysteine-type endopeptidase activity,GO:0004252~serine-type endopeptidase activity,GO:0005515~protein binding,"	"hsa04071:Sphingolipid signaling pathway,hsa04142:Lysosome,hsa05152:Tuberculosis,"	"610127~Ceroid lipofuscinosis, neuronal, 10,"	"R-HSA-1442490:R-HSA-1442490,R-HSA-2022377:R-HSA-2022377,R-HSA-2132295:R-HSA-2132295,"
CP	ceruloplasmin(CP)	Homo sapiens	"GO:0006825~copper ion transport,GO:0006879~cellular iron ion homeostasis,GO:0055114~oxidation-reduction process,"	"GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005623~cell,GO:0005765~lysosomal membrane,GO:0070062~extracellular exosome,GO:0072562~blood microparticle,"	"GO:0004322~ferroxidase activity,GO:0005507~copper ion binding,GO:0051087~chaperone binding,"	"hsa00860:Porphyrin and chlorophyll metabolism,"	"604290~Cerebellar ataxia,604290~Hemosiderosis, systemic, due to aceruloplasminemia,604290~Hypoceruloplasminemia, hereditary,"	"R-HSA-425410:R-HSA-425410,R-HSA-5619060:R-HSA-5619060,R-HSA-917937:R-HSA-917937,"
CHI3L1	chitinase 3 like 1(CHI3L1)	Homo sapiens	"GO:0005975~carbohydrate metabolic process,GO:0006032~chitin catabolic process,GO:0006915~apoptotic process,GO:0006954~inflammatory response,GO:0007250~activation of NF-kappaB-inducing kinase activity,GO:0009612~response to mechanical stimulus,GO:0010800~positive regulation of peptidyl-threonine phosphorylation,GO:0030324~lung development,GO:0034612~response to tumor necrosis factor,GO:0045766~positive regulation of angiogenesis,GO:0051216~cartilage development,GO:0051897~positive regulation of protein kinase B signaling,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0070555~response to interleukin-1,GO:0070741~response to interleukin-6,GO:0071347~cellular response to interleukin-1,GO:0071356~cellular response to tumor necrosis factor,GO:0072606~interleukin-8 secretion,"	"GO:0005578~proteinaceous extracellular matrix,GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,"	"GO:0004553~hydrolase activity, hydrolyzing O-glycosyl compounds,GO:0004568~chitinase activity,GO:0005201~extracellular matrix structural constituent,GO:0008061~chitin binding,GO:0030246~carbohydrate binding,"		"181500~Schizophrenia, susceptibility to,611960~Asthma-related traits, susceptibility to, 7,"	
C1QB	complement C1q B chain(C1QB)	Homo sapiens	"GO:0006508~proteolysis,GO:0006956~complement activation,GO:0006958~complement activation, classical pathway,GO:0045087~innate immune response,GO:0048839~inner ear development,"	"GO:0005576~extracellular region,GO:0005581~collagen trimer,GO:0005602~complement component C1 complex,GO:0070062~extracellular exosome,GO:0072562~blood microparticle,"	"GO:0004252~serine-type endopeptidase activity,GO:0005515~protein binding,GO:0042803~protein homodimerization activity,"	"hsa04610:Complement and coagulation cascades,hsa05020:Prion diseases,hsa05133:Pertussis,hsa05142:Chagas disease (American trypanosomiasis),hsa05150:Staphylococcus aureus infection,hsa05322:Systemic lupus erythematosus,"	"613652~C1q deficiency,"	"R-HSA-166663:R-HSA-166663,R-HSA-173623:R-HSA-173623,"
CFB	complement factor B(CFB)	Homo sapiens	"GO:0006508~proteolysis,GO:0006956~complement activation,GO:0006957~complement activation, alternative pathway,GO:0030449~regulation of complement activation,"	"GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0070062~extracellular exosome,GO:0072562~blood microparticle,"	"GO:0001848~complement binding,GO:0004252~serine-type endopeptidase activity,"	"hsa04610:Complement and coagulation cascades,hsa05150:Staphylococcus aureus infection,"	"612924~Hemolytic uremic syndrome, atypical, susceptibility to, 4,615489~Macular degeneration, age-related, 14, reduced risk of,615561~Complement factor B deficiency,"	"R-HSA-173736:R-HSA-173736,R-HSA-174577:R-HSA-174577,R-HSA-977606:R-HSA-977606,"
CFI	complement factor I(CFI)	Homo sapiens	"GO:0006508~proteolysis,GO:0006898~receptor-mediated endocytosis,GO:0006958~complement activation, classical pathway,GO:0030449~regulation of complement activation,GO:0045087~innate immune response,"	"GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0016020~membrane,GO:0070062~extracellular exosome,"	"GO:0004252~serine-type endopeptidase activity,GO:0005044~scavenger receptor activity,GO:0005515~protein binding,GO:0046872~metal ion binding,"	"hsa04610:Complement and coagulation cascades,hsa05150:Staphylococcus aureus infection,"	"610984~Complement factor I deficiency,612923~Hemolytic uremic syndrome, atypical, susceptibility to, 3,615439~Macular degeneration, age-related, 13, susceptibility to,"	"R-HSA-977606:R-HSA-977606,"
CSTB	cystatin B(CSTB)	Homo sapiens	"GO:0008344~adult locomotory behavior,GO:0010466~negative regulation of peptidase activity,GO:0010951~negative regulation of endopeptidase activity,GO:0045861~negative regulation of proteolysis,"	"GO:0005615~extracellular space,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0070062~extracellular exosome,"	"GO:0002020~protease binding,GO:0004866~endopeptidase inhibitor activity,GO:0004869~cysteine-type endopeptidase inhibitor activity,GO:0044822~poly(A) RNA binding,"		"254800~Epilepsy, progressive myoclonic 1A (Unverricht and Lundborg),"	
CST5	cystatin D(CST5)	Homo sapiens	"GO:2000117~negative regulation of cysteine-type endopeptidase activity,"	"GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0070062~extracellular exosome,"	"GO:0002020~protease binding,GO:0004869~cysteine-type endopeptidase inhibitor activity,GO:0005515~protein binding,"	"hsa04970:Salivary secretion,"		
ESM1	endothelial cell specific molecule 1(ESM1)	Homo sapiens	"GO:0001525~angiogenesis,GO:0001558~regulation of cell growth,GO:0002040~sprouting angiogenesis,GO:0008284~positive regulation of cell proliferation,GO:1902204~positive regulation of hepatocyte growth factor receptor signaling pathway,"	"GO:0005576~extracellular region,"	"GO:0005171~hepatocyte growth factor receptor binding,GO:0005178~integrin binding,GO:0005520~insulin-like growth factor binding,"			
FGA	fibrinogen alpha chain(FGA)	Homo sapiens	"GO:0002250~adaptive immune response,GO:0002576~platelet degranulation,GO:0006461~protein complex assembly,GO:0007160~cell-matrix adhesion,GO:0007165~signal transduction,GO:0007596~blood coagulation,GO:0030168~platelet activation,GO:0030198~extracellular matrix organization,GO:0031639~plasminogen activation,GO:0034116~positive regulation of heterotypic cell-cell adhesion,GO:0042730~fibrinolysis,GO:0043152~induction of bacterial agglutination,GO:0043623~cellular protein complex assembly,GO:0044267~cellular protein metabolic process,GO:0045087~innate immune response,GO:0045907~positive regulation of vasoconstriction,GO:0045921~positive regulation of exocytosis,GO:0050714~positive regulation of protein secretion,GO:0051258~protein polymerization,GO:0051592~response to calcium ion,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0070527~platelet aggregation,GO:0072377~blood coagulation, common pathway,GO:0072378~blood coagulation, fibrin clot formation,GO:0090277~positive regulation of peptide hormone secretion,GO:1900026~positive regulation of substrate adhesion-dependent cell spreading,GO:1902042~negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,GO:2000261~negative regulation of blood coagulation, common pathway,GO:2000352~negative regulation of endothelial cell apoptotic process,"	"GO:0005576~extracellular region,GO:0005577~fibrinogen complex,GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0005938~cell cortex,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0031091~platelet alpha granule,GO:0031093~platelet alpha granule lumen,GO:0070062~extracellular exosome,GO:0072562~blood microparticle,GO:1903561~extracellular vesicle,"	"GO:0005102~receptor binding,GO:0005198~structural molecule activity,GO:0005515~protein binding,GO:0030674~protein binding, bridging,GO:0046872~metal ion binding,GO:0050839~cell adhesion molecule binding,"	"hsa04610:Complement and coagulation cascades,hsa04611:Platelet activation,"	"105200~Amyloidosis, familial visceral,202400~Afibrinogenemia, congenital,616004~Dysfibrinogenemia, congenital,616004~Hypodysfibrinogenemia, congenital,"	"R-HSA-114608:R-HSA-114608,R-HSA-140875:R-HSA-140875,R-HSA-216083:R-HSA-216083,R-HSA-354192:R-HSA-354192,R-HSA-354194:R-HSA-354194,R-HSA-372708:R-HSA-372708,R-HSA-5674135:R-HSA-5674135,R-HSA-977225:R-HSA-977225,"
FGG	fibrinogen gamma chain(FGG)	Homo sapiens	"GO:0002576~platelet degranulation,GO:0007160~cell-matrix adhesion,GO:0007165~signal transduction,GO:0007596~blood coagulation,GO:0009306~protein secretion,GO:0030168~platelet activation,GO:0030198~extracellular matrix organization,GO:0031639~plasminogen activation,GO:0034116~positive regulation of heterotypic cell-cell adhesion,GO:0042730~fibrinolysis,GO:0043623~cellular protein complex assembly,GO:0045907~positive regulation of vasoconstriction,GO:0045921~positive regulation of exocytosis,GO:0050714~positive regulation of protein secretion,GO:0051258~protein polymerization,GO:0051592~response to calcium ion,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0070527~platelet aggregation,GO:0072378~blood coagulation, fibrin clot formation,GO:0090277~positive regulation of peptide hormone secretion,GO:1900026~positive regulation of substrate adhesion-dependent cell spreading,GO:1902042~negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,GO:2000352~negative regulation of endothelial cell apoptotic process,"	"GO:0005576~extracellular region,GO:0005577~fibrinogen complex,GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0005938~cell cortex,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0031091~platelet alpha granule,GO:0031093~platelet alpha granule lumen,GO:0070062~extracellular exosome,GO:0072562~blood microparticle,"	"GO:0005102~receptor binding,GO:0005198~structural molecule activity,GO:0005515~protein binding,GO:0030674~protein binding, bridging,GO:0046872~metal ion binding,GO:0050839~cell adhesion molecule binding,"	"hsa04610:Complement and coagulation cascades,hsa04611:Platelet activation,hsa05150:Staphylococcus aureus infection,"	"202400~Afibrinogenemia, congenital,202400~Hypofibrinogenemia, congenital,616004~Dysfibrinogenemia, congenital,616004~Hypodysfibrinogenemia,"	"R-HSA-114608:R-HSA-114608,R-HSA-140875:R-HSA-140875,R-HSA-216083:R-HSA-216083,R-HSA-354192:R-HSA-354192,R-HSA-354194:R-HSA-354194,R-HSA-372708:R-HSA-372708,R-HSA-5674135:R-HSA-5674135,"
FGF21	fibroblast growth factor 21(FGF21)	Homo sapiens	"GO:0007165~signal transduction,GO:0007267~cell-cell signaling,GO:0008284~positive regulation of cell proliferation,GO:0010898~positive regulation of triglyceride catabolic process,GO:0010988~regulation of low-density lipoprotein particle clearance,GO:0014823~response to activity,GO:0030968~endoplasmic reticulum unfolded protein response,GO:0031667~response to nutrient levels,GO:0035690~cellular response to drug,GO:0045716~positive regulation of low-density lipoprotein particle receptor biosynthetic process,GO:0046326~positive regulation of glucose import,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0071333~cellular response to glucose stimulus,GO:0071377~cellular response to glucagon stimulus,GO:0071404~cellular response to low-density lipoprotein particle stimulus,GO:0072577~endothelial cell apoptotic process,GO:0090080~positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway,GO:1901215~negative regulation of neuron death,GO:1904640~response to methionine,GO:2000352~negative regulation of endothelial cell apoptotic process,"	"GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005623~cell,"	"GO:0005104~fibroblast growth factor receptor binding,GO:0005515~protein binding,GO:0008083~growth factor activity,"	"hsa04010:MAPK signaling pathway,hsa04014:Ras signaling pathway,hsa04015:Rap1 signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04810:Regulation of actin cytoskeleton,hsa05200:Pathways in cancer,hsa05218:Melanoma,"		"R-HSA-174800:R-HSA-174800,R-HSA-428790:R-HSA-428790,R-HSA-70153:R-HSA-70153,"
FGF5	fibroblast growth factor 5(FGF5)	Homo sapiens	"GO:0000165~MAPK cascade,GO:0007267~cell-cell signaling,GO:0007399~nervous system development,GO:0008283~cell proliferation,GO:0008284~positive regulation of cell proliferation,GO:0008543~fibroblast growth factor receptor signaling pathway,GO:0010001~glial cell differentiation,GO:0014066~regulation of phosphatidylinositol 3-kinase signaling,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0023019~signal transduction involved in regulation of gene expression,GO:0036092~phosphatidylinositol-3-phosphate biosynthetic process,GO:0043547~positive regulation of GTPase activity,GO:0046854~phosphatidylinositol phosphorylation,GO:0048015~phosphatidylinositol-mediated signaling,GO:0051781~positive regulation of cell division,"	"GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005622~intracellular,"	"GO:0004713~protein tyrosine kinase activity,GO:0005088~Ras guanyl-nucleotide exchange factor activity,GO:0005104~fibroblast growth factor receptor binding,GO:0008083~growth factor activity,GO:0016303~1-phosphatidylinositol-3-kinase activity,GO:0046934~phosphatidylinositol-4,5-bisphosphate 3-kinase activity,"	"hsa04010:MAPK signaling pathway,hsa04014:Ras signaling pathway,hsa04015:Rap1 signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04810:Regulation of actin cytoskeleton,hsa05200:Pathways in cancer,hsa05218:Melanoma,"	"190330~Trichomegaly,"	"R-HSA-109704:R-HSA-109704,R-HSA-1257604:R-HSA-1257604,R-HSA-1839122:R-HSA-1839122,R-HSA-1839130:R-HSA-1839130,R-HSA-190372:R-HSA-190372,R-HSA-190373:R-HSA-190373,R-HSA-190375:R-HSA-190375,R-HSA-2033514:R-HSA-2033514,R-HSA-2033519:R-HSA-2033519,R-HSA-2219530:R-HSA-2219530,R-HSA-5654219:R-HSA-5654219,R-HSA-5654221:R-HSA-5654221,R-HSA-5654227:R-HSA-5654227,R-HSA-5654687:R-HSA-5654687,R-HSA-5654688:R-HSA-5654688,R-HSA-5654689:R-HSA-5654689,R-HSA-5654693:R-HSA-5654693,R-HSA-5654695:R-HSA-5654695,R-HSA-5654699:R-HSA-5654699,R-HSA-5654700:R-HSA-5654700,R-HSA-5654704:R-HSA-5654704,R-HSA-5654706:R-HSA-5654706,R-HSA-5654710:R-HSA-5654710,R-HSA-5654726:R-HSA-5654726,R-HSA-5654727:R-HSA-5654727,R-HSA-5654732:R-HSA-5654732,R-HSA-5655253:R-HSA-5655253,R-HSA-5655302:R-HSA-5655302,R-HSA-5673001:R-HSA-5673001,"
FBLN1	fibulin 1(FBLN1)	Homo sapiens	"GO:0001933~negative regulation of protein phosphorylation,GO:0007162~negative regulation of cell adhesion,GO:0007229~integrin-mediated signaling pathway,GO:0007566~embryo implantation,GO:0010628~positive regulation of gene expression,GO:0010952~positive regulation of peptidase activity,GO:0016032~viral process,GO:0030198~extracellular matrix organization,GO:0048146~positive regulation of fibroblast proliferation,GO:0070373~negative regulation of ERK1 and ERK2 cascade,GO:0072378~blood coagulation, fibrin clot formation,GO:1900025~negative regulation of substrate adhesion-dependent cell spreading,GO:1904188~negative regulation of transformation of host cell by virus,GO:1904237~positive regulation of substrate-dependent cell migration, cell attachment to substrate,GO:2000146~negative regulation of cell motility,GO:2000647~negative regulation of stem cell proliferation,GO:2001202~negative regulation of transforming growth factor-beta secretion,"	"GO:0005576~extracellular region,GO:0005577~fibrinogen complex,GO:0005578~proteinaceous extracellular matrix,GO:0005604~basement membrane,GO:0005615~extracellular space,GO:0005622~intracellular,GO:0031012~extracellular matrix,GO:0070062~extracellular exosome,GO:0071953~elastic fiber,"	"GO:0001968~fibronectin binding,GO:0005178~integrin binding,GO:0005201~extracellular matrix structural constituent,GO:0005509~calcium ion binding,GO:0008022~protein C-terminus binding,GO:0016504~peptidase activator activity,GO:0032403~protein complex binding,GO:0042802~identical protein binding,GO:0070051~fibrinogen binding,"		"608180~Synpolydactyly, 3/3'4, associated with metacarpal and metatarsal synostoses,"	"R-HSA-2129379:R-HSA-2129379,"
FCN3	ficolin 3(FCN3)	Homo sapiens	"GO:0001867~complement activation, lectin pathway,GO:0006508~proteolysis,GO:0006956~complement activation,GO:0043654~recognition of apoptotic cell,GO:0046597~negative regulation of viral entry into host cell,GO:0051607~defense response to virus,GO:1902679~negative regulation of RNA biosynthetic process,"	"GO:0005576~extracellular region,GO:0005581~collagen trimer,GO:0072562~blood microparticle,"	"GO:0003823~antigen binding,GO:0004252~serine-type endopeptidase activity,GO:0005515~protein binding,GO:0030246~carbohydrate binding,GO:0046872~metal ion binding,"		"613860~Immunodeficiency due to ficolin 3 deficiency,"	"R-HSA-166662:R-HSA-166662,R-HSA-166663:R-HSA-166663,R-HSA-2855086:R-HSA-2855086,"
FLT3LG	fms related tyrosine kinase 3 ligand(FLT3LG)	Homo sapiens	"GO:0001934~positive regulation of protein phosphorylation,GO:0007165~signal transduction,GO:0008284~positive regulation of cell proliferation,GO:0030098~lymphocyte differentiation,GO:0030885~regulation of myeloid dendritic cell activation,GO:0032825~positive regulation of natural killer cell differentiation,GO:0035162~embryonic hemopoiesis,GO:0045663~positive regulation of myoblast differentiation,GO:0045787~positive regulation of cell cycle,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048873~homeostasis of number of cells within a tissue,GO:0071864~positive regulation of cell proliferation in bone marrow,GO:0071866~negative regulation of apoptotic process in bone marrow,GO:0090290~positive regulation of osteoclast proliferation,GO:1901741~positive regulation of myoblast fusion,"	"GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0031233~intrinsic component of external side of plasma membrane,"	"GO:0005102~receptor binding,GO:0005125~cytokine activity,GO:0016301~kinase activity,GO:0030971~receptor tyrosine kinase binding,GO:0042803~protein homodimerization activity,"	"hsa04640:Hematopoietic cell lineage,hsa05200:Pathways in cancer,"		"R-HSA-449147:R-HSA-449147,"
GSN	gelsolin(GSN)	Homo sapiens	"GO:0006911~phagocytosis, engulfment,GO:0010628~positive regulation of gene expression,GO:0014891~striated muscle atrophy,GO:0022617~extracellular matrix disassembly,GO:0030041~actin filament polymerization,GO:0031648~protein destabilization,GO:0042989~sequestering of actin monomers,GO:0044267~cellular protein metabolic process,GO:0045010~actin nucleation,GO:0046597~negative regulation of viral entry into host cell,GO:0051014~actin filament severing,GO:0051016~barbed-end actin filament capping,GO:0051127~positive regulation of actin nucleation,GO:0051693~actin filament capping,GO:0060271~cilium morphogenesis,GO:0071801~regulation of podosome assembly,GO:0090527~actin filament reorganization,GO:0097017~renal protein absorption,GO:0097284~hepatocyte apoptotic process,GO:1902174~positive regulation of keratinocyte apoptotic process,GO:1903689~regulation of wound healing, spreading of epidermal cells,GO:1903903~regulation of establishment of T cell polarity,GO:1903906~regulation of plasma membrane raft polarization,GO:1903909~regulation of receptor clustering,GO:1903923~positive regulation of protein processing in phagocytic vesicle,GO:1990000~amyloid fibril formation,GO:2001269~positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,"	"GO:0002102~podosome,GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0015629~actin cytoskeleton,GO:0016528~sarcoplasm,GO:0030478~actin cap,GO:0030864~cortical actin cytoskeleton,GO:0070062~extracellular exosome,GO:0072562~blood microparticle,"	"GO:0003779~actin binding,GO:0005509~calcium ion binding,GO:0005515~protein binding,GO:0019904~protein domain specific binding,GO:0045159~myosin II binding,"	"hsa04666:Fc gamma R-mediated phagocytosis,hsa04810:Regulation of actin cytoskeleton,hsa05203:Viral carcinogenesis,"	"105120~Amyloidosis, Finnish type,"	"R-HSA-264870:R-HSA-264870,R-HSA-977225:R-HSA-977225,"
GDF15	growth differentiation factor 15(GDF15)	Homo sapiens	"GO:0007165~signal transduction,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0007267~cell-cell signaling,GO:0010862~positive regulation of pathway-restricted SMAD protein phosphorylation,GO:0042981~regulation of apoptotic process,GO:0043408~regulation of MAPK cascade,GO:0048468~cell development,GO:0060395~SMAD protein signal transduction,GO:1901741~positive regulation of myoblast fusion,"	"GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0070062~extracellular exosome,"	"GO:0005125~cytokine activity,GO:0005160~transforming growth factor beta receptor binding,GO:0005515~protein binding,GO:0008083~growth factor activity,"			
GH1	growth hormone 1(GH1)	Homo sapiens	"GO:0002092~positive regulation of receptor internalization,GO:0007259~JAK-STAT cascade,GO:0010535~positive regulation of activation of JAK2 kinase activity,GO:0014068~positive regulation of phosphatidylinositol 3-kinase signaling,GO:0015758~glucose transport,GO:0032355~response to estradiol,GO:0040018~positive regulation of multicellular organism growth,GO:0042517~positive regulation of tyrosine phosphorylation of Stat3 protein,GO:0042523~positive regulation of tyrosine phosphorylation of Stat5 protein,GO:0043406~positive regulation of MAP kinase activity,GO:0043568~positive regulation of insulin-like growth factor receptor signaling pathway,GO:0046427~positive regulation of JAK-STAT cascade,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0060396~growth hormone receptor signaling pathway,GO:0060397~JAK-STAT cascade involved in growth hormone signaling pathway,GO:0070977~bone maturation,"	"GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005622~intracellular,"	"GO:0005131~growth hormone receptor binding,GO:0005148~prolactin receptor binding,GO:0005179~hormone activity,GO:0005515~protein binding,GO:0008083~growth factor activity,GO:0046872~metal ion binding,"	"hsa04060:Cytokine-cytokine receptor interaction,hsa04080:Neuroactive ligand-receptor interaction,hsa04151:PI3K-Akt signaling pathway,hsa04630:Jak-STAT signaling pathway,"	"173100~Growth hormone deficiency, isolated, type II,262400~Growth hormone deficiency, isolated, type IA,262650~Kowarski syndrome,612781~Growth hormone deficiency, isolated, type IB,"	"R-HSA-1170546:R-HSA-1170546,R-HSA-422085:R-HSA-422085,R-HSA-982772:R-HSA-982772,"
IGHA2	immunoglobulin heavy constant alpha 2 (A2m marker)(IGHA2)	Homo sapiens	"GO:0001895~retina homeostasis,GO:0003094~glomerular filtration,GO:0006898~receptor-mediated endocytosis,GO:0006910~phagocytosis, recognition,GO:0006911~phagocytosis, engulfment,GO:0006955~immune response,GO:0006958~complement activation, classical pathway,GO:0019731~antibacterial humoral response,GO:0045087~innate immune response,GO:0050853~B cell receptor signaling pathway,GO:0050871~positive regulation of B cell activation,GO:0060267~positive regulation of respiratory burst,"	"GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0009897~external side of plasma membrane,GO:0070062~extracellular exosome,GO:0071748~monomeric IgA immunoglobulin complex,GO:0071751~secretory IgA immunoglobulin complex,GO:0071752~secretory dimeric IgA immunoglobulin complex,GO:0072562~blood microparticle,"	"GO:0003823~antigen binding,GO:0034987~immunoglobulin receptor binding,"			"R-HSA-2168880:R-HSA-2168880,"
IGHG3	immunoglobulin heavy constant gamma 3 (G3m marker)(IGHG3)	Homo sapiens	"GO:0001895~retina homeostasis,GO:0006508~proteolysis,GO:0006910~phagocytosis, recognition,GO:0006911~phagocytosis, engulfment,GO:0006956~complement activation,GO:0006958~complement activation, classical pathway,GO:0038096~Fc-gamma receptor signaling pathway involved in phagocytosis,GO:0042742~defense response to bacterium,GO:0045087~innate immune response,GO:0050853~B cell receptor signaling pathway,GO:0050871~positive regulation of B cell activation,"	"GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0009897~external side of plasma membrane,GO:0042571~immunoglobulin complex, circulating,GO:0070062~extracellular exosome,GO:0072562~blood microparticle,"	"GO:0003823~antigen binding,GO:0004252~serine-type endopeptidase activity,GO:0034987~immunoglobulin receptor binding,"			"R-HSA-166663:R-HSA-166663,R-HSA-173623:R-HSA-173623,R-HSA-2029481:R-HSA-2029481,R-HSA-2029482:R-HSA-2029482,R-HSA-2029485:R-HSA-2029485,"
IGHG4	immunoglobulin heavy constant gamma 4 (G4m marker)(IGHG4)	Homo sapiens	"GO:0006508~proteolysis,GO:0006910~phagocytosis, recognition,GO:0006911~phagocytosis, engulfment,GO:0006956~complement activation,GO:0006958~complement activation, classical pathway,GO:0038096~Fc-gamma receptor signaling pathway involved in phagocytosis,GO:0042742~defense response to bacterium,GO:0045087~innate immune response,GO:0050853~B cell receptor signaling pathway,GO:0050871~positive regulation of B cell activation,"	"GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0009897~external side of plasma membrane,GO:0042571~immunoglobulin complex, circulating,GO:0070062~extracellular exosome,GO:0072562~blood microparticle,"	"GO:0003823~antigen binding,GO:0004252~serine-type endopeptidase activity,GO:0034987~immunoglobulin receptor binding,"			"R-HSA-166663:R-HSA-166663,R-HSA-173623:R-HSA-173623,R-HSA-2029481:R-HSA-2029481,R-HSA-2029482:R-HSA-2029482,R-HSA-2029485:R-HSA-2029485,"
IL10RB	interleukin 10 receptor subunit beta(IL10RB)	Homo sapiens	"GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007165~signal transduction,GO:0019221~cytokine-mediated signaling pathway,GO:0051607~defense response to virus,"	"GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0032002~interleukin-28 receptor complex,GO:0070062~extracellular exosome,"	"GO:0004872~receptor activity,GO:0004920~interleukin-10 receptor activity,GO:0005515~protein binding,"	"hsa04060:Cytokine-cytokine receptor interaction,hsa04630:Jak-STAT signaling pathway,hsa05145:Toxoplasmosis,hsa05152:Tuberculosis,"	"610424~Hepatitis B virus, susceptibility to,612567~Inflammatory bowel disease 25, early onset, autosomal recessive,"	"R-HSA-449147:R-HSA-449147,"
IL10	interleukin 10(IL10)	Homo sapiens	"GO:0002237~response to molecule of bacterial origin,GO:0002740~negative regulation of cytokine secretion involved in immune response,GO:0002875~negative regulation of chronic inflammatory response to antigenic stimulus,GO:0002904~positive regulation of B cell apoptotic process,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007253~cytoplasmic sequestering of NF-kappaB,GO:0007267~cell-cell signaling,GO:0007568~aging,GO:0008285~negative regulation of cell proliferation,GO:0010468~regulation of gene expression,GO:0014823~response to activity,GO:0014854~response to inactivity,GO:0030097~hemopoiesis,GO:0030183~B cell differentiation,GO:0030595~leukocyte chemotaxis,GO:0030886~negative regulation of myeloid dendritic cell activation,GO:0030889~negative regulation of B cell proliferation,GO:0032689~negative regulation of interferon-gamma production,GO:0032692~negative regulation of interleukin-1 production,GO:0032695~negative regulation of interleukin-12 production,GO:0032701~negative regulation of interleukin-18 production,GO:0032715~negative regulation of interleukin-6 production,GO:0032717~negative regulation of interleukin-8 production,GO:0032720~negative regulation of tumor necrosis factor production,GO:0032800~receptor biosynthetic process,GO:0032868~response to insulin,GO:0034115~negative regulation of heterotypic cell-cell adhesion,GO:0034116~positive regulation of heterotypic cell-cell adhesion,GO:0034465~response to carbon monoxide,GO:0035729~cellular response to hepatocyte growth factor stimulus,GO:0042092~type 2 immune response,GO:0042100~B cell proliferation,GO:0042130~negative regulation of T cell proliferation,GO:0042493~response to drug,GO:0042536~negative regulation of tumor necrosis factor biosynthetic process,GO:0042742~defense response to bacterium,GO:0042832~defense response to protozoan,GO:0043032~positive regulation of macrophage activation,GO:0043066~negative regulation of apoptotic process,GO:0044130~negative regulation of growth of symbiont in host,GO:0045019~negative regulation of nitric oxide biosynthetic process,GO:0045191~regulation of isotype switching,GO:0045347~negative regulation of MHC class II biosynthetic process,GO:0045348~positive regulation of MHC class II biosynthetic process,GO:0045355~negative regulation of interferon-alpha biosynthetic process,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045930~negative regulation of mitotic cell cycle,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046427~positive regulation of JAK-STAT cascade,GO:0050715~positive regulation of cytokine secretion,GO:0050807~regulation of synapse organization,GO:0051045~negative regulation of membrane protein ectodomain proteolysis,GO:0051091~positive regulation of sequence-specific DNA binding transcription factor activity,GO:0051384~response to glucocorticoid,GO:0060302~negative regulation of cytokine activity,GO:0060670~branching involved in labyrinthine layer morphogenesis,GO:0071222~cellular response to lipopolysaccharide,GO:0071392~cellular response to estradiol stimulus,GO:0071650~negative regulation of chemokine (C-C motif) ligand 5 production,GO:0072577~endothelial cell apoptotic process,GO:0097421~liver regeneration,GO:1903034~regulation of response to wounding,GO:1903659~regulation of complement-dependent cytotoxicity,GO:1904057~negative regulation of sensory perception of pain,GO:1904706~negative regulation of vascular smooth muscle cell proliferation,GO:1904707~positive regulation of vascular smooth muscle cell proliferation,GO:2000352~negative regulation of endothelial cell apoptotic process,"	"GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005737~cytoplasm,"	"GO:0005125~cytokine activity,GO:0005141~interleukin-10 receptor binding,GO:0005515~protein binding,GO:0008083~growth factor activity,"	"hsa04060:Cytokine-cytokine receptor interaction,hsa04068:FoxO signaling pathway,hsa04630:Jak-STAT signaling pathway,hsa04660:T cell receptor signaling pathway,hsa04672:Intestinal immune network for IgA production,hsa05133:Pertussis,hsa05140:Leishmaniasis,hsa05142:Chagas disease (American trypanosomiasis),hsa05143:African trypanosomiasis,hsa05144:Malaria,hsa05145:Toxoplasmosis,hsa05146:Amoebiasis,hsa05150:Staphylococcus aureus infection,hsa05152:Tuberculosis,hsa05310:Asthma,hsa05320:Autoimmune thyroid disease,hsa05321:Inflammatory bowel disease (IBD),hsa05322:Systemic lupus erythematosus,hsa05330:Allograft rejection,"	"180300~Rheumatoid arthritis, progression of,609423~HIV-1, susceptibility to,614395~Graft-versus-host disease, protection against,"	
IL15RA	interleukin 15 receptor subunit alpha(IL15RA)	Homo sapiens	"GO:0007165~signal transduction,GO:0007259~JAK-STAT cascade,GO:0008283~cell proliferation,GO:0010977~negative regulation of neuron projection development,GO:0019221~cytokine-mediated signaling pathway,GO:0031667~response to nutrient levels,GO:0032825~positive regulation of natural killer cell differentiation,"	"GO:0000139~Golgi membrane,GO:0005615~extracellular space,GO:0005789~endoplasmic reticulum membrane,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,GO:0030659~cytoplasmic vesicle membrane,GO:0031410~cytoplasmic vesicle,GO:0031965~nuclear membrane,"	"GO:0004871~signal transducer activity,GO:0004896~cytokine receptor activity,GO:0005515~protein binding,"	"hsa04060:Cytokine-cytokine receptor interaction,hsa04630:Jak-STAT signaling pathway,hsa04672:Intestinal immune network for IgA production,hsa05166:HTLV-I infection,"		"R-HSA-449147:R-HSA-449147,"
IL6	interleukin 6(IL6)	Homo sapiens	"GO:0001781~neutrophil apoptotic process,GO:0001878~response to yeast,GO:0002384~hepatic immune response,GO:0002446~neutrophil mediated immunity,GO:0002526~acute inflammatory response,GO:0002548~monocyte chemotaxis,GO:0002675~positive regulation of acute inflammatory response,GO:0002690~positive regulation of leukocyte chemotaxis,GO:0006469~negative regulation of protein kinase activity,GO:0006953~acute-phase response,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0006959~humoral immune response,GO:0007568~aging,GO:0008284~positive regulation of cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0008360~regulation of cell shape,GO:0009408~response to heat,GO:0009409~response to cold,GO:0010574~regulation of vascular endothelial growth factor production,GO:0010628~positive regulation of gene expression,GO:0010888~negative regulation of lipid storage,GO:0010976~positive regulation of neuron projection development,GO:0010996~response to auditory stimulus,GO:0016049~cell growth,GO:0019221~cytokine-mediated signaling pathway,GO:0030168~platelet activation,GO:0031000~response to caffeine,GO:0031018~endocrine pancreas development,GO:0031175~neuron projection development,GO:0031669~cellular response to nutrient levels,GO:0032494~response to peptidoglycan,GO:0032722~positive regulation of chemokine production,GO:0032755~positive regulation of interleukin-6 production,GO:0032868~response to insulin,GO:0032966~negative regulation of collagen biosynthetic process,GO:0033138~positive regulation of peptidyl-serine phosphorylation,GO:0033160~positive regulation of protein import into nucleus, translocation,GO:0035729~cellular response to hepatocyte growth factor stimulus,GO:0042060~wound healing,GO:0042102~positive regulation of T cell proliferation,GO:0042493~response to drug,GO:0042517~positive regulation of tyrosine phosphorylation of Stat3 protein,GO:0042593~glucose homeostasis,GO:0042832~defense response to protozoan,GO:0043065~positive regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0043154~negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0043200~response to amino acid,GO:0043410~positive regulation of MAPK cascade,GO:0045079~negative regulation of chemokine biosynthetic process,GO:0045188~regulation of circadian sleep/wake cycle, non-REM sleep,GO:0045429~positive regulation of nitric oxide biosynthetic process,GO:0045454~cell redox homeostasis,GO:0045599~negative regulation of fat cell differentiation,GO:0045630~positive regulation of T-helper 2 cell differentiation,GO:0045669~positive regulation of osteoblast differentiation,GO:0045721~negative regulation of gluconeogenesis,GO:0045727~positive regulation of translation,GO:0045740~positive regulation of DNA replication,GO:0045765~regulation of angiogenesis,GO:0045779~negative regulation of bone resorption,GO:0045837~negative regulation of membrane potential,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046427~positive regulation of JAK-STAT cascade,GO:0046677~response to antibiotic,GO:0046716~muscle cell cellular homeostasis,GO:0046849~bone remodeling,GO:0046888~negative regulation of hormone secretion,GO:0048635~negative regulation of muscle organ development,GO:0048661~positive regulation of smooth muscle cell proliferation,GO:0050679~positive regulation of epithelial cell proliferation,GO:0050710~negative regulation of cytokine secretion,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0050829~defense response to Gram-negative bacterium,GO:0050830~defense response to Gram-positive bacterium,GO:0050871~positive regulation of B cell activation,GO:0051024~positive regulation of immunoglobulin secretion,GO:0051091~positive regulation of sequence-specific DNA binding transcription factor activity,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0051384~response to glucocorticoid,GO:0051592~response to calcium ion,GO:0051602~response to electrical stimulus,GO:0051607~defense response to virus,GO:0051897~positive regulation of protein kinase B signaling,GO:0051971~positive regulation of transmission of nerve impulse,GO:0060445~branching involved in salivary gland morphogenesis,GO:0060664~epithelial cell proliferation involved in salivary gland morphogenesis,GO:0070091~glucagon secretion,GO:0070102~interleukin-6-mediated signaling pathway,GO:0070301~cellular response to hydrogen peroxide,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0071222~cellular response to lipopolysaccharide,GO:0071347~cellular response to interleukin-1,GO:0071356~cellular response to tumor necrosis factor,GO:0071392~cellular response to estradiol stimulus,GO:0071549~cellular response to dexamethasone stimulus,GO:0071864~positive regulation of cell proliferation in bone marrow,GO:0072540~T-helper 17 cell lineage commitment,GO:1901215~negative regulation of neuron death,GO:1990646~cellular response to prolactin,GO:2000366~positive regulation of STAT protein import into nucleus,GO:2000553~positive regulation of T-helper 2 cell cytokine production,GO:2000660~negative regulation of interleukin-1-mediated signaling pathway,GO:2000676~positive regulation of type B pancreatic cell apoptotic process,"	"GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0005896~interleukin-6 receptor complex,GO:0009897~external side of plasma membrane,"	"GO:0005125~cytokine activity,GO:0005138~interleukin-6 receptor binding,GO:0005515~protein binding,GO:0008083~growth factor activity,"	"hsa04060:Cytokine-cytokine receptor interaction,hsa04066:HIF-1 signaling pathway,hsa04068:FoxO signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04620:Toll-like receptor signaling pathway,hsa04621:NOD-like receptor signaling pathway,hsa04623:Cytosolic DNA-sensing pathway,hsa04630:Jak-STAT signaling pathway,hsa04640:Hematopoietic cell lineage,hsa04668:TNF signaling pathway,hsa04672:Intestinal immune network for IgA production,hsa04931:Insulin resistance,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa05020:Prion diseases,hsa05132:Salmonella infection,hsa05133:Pertussis,hsa05134:Legionellosis,hsa05142:Chagas disease (American trypanosomiasis),hsa05143:African trypanosomiasis,hsa05144:Malaria,hsa05146:Amoebiasis,hsa05152:Tuberculosis,hsa05161:Hepatitis B,hsa05162:Measles,hsa05164:Influenza A,hsa05166:HTLV-I infection,hsa05168:Herpes simplex infection,hsa05200:Pathways in cancer,hsa05202:Transcriptional misregulation in cancer,hsa05321:Inflammatory bowel disease (IBD),hsa05323:Rheumatoid arthritis,hsa05332:Graft-versus-host disease,hsa05410:Hypertrophic cardiomyopathy (HCM),"	"108010~Intracranial hemorrhage in brain cerebrovascular malformations, susceptibility to,125853~Diabetes, susceptibility to, 222100,148000~Kaposi sarcoma, susceptibility to,266600~Crohn disease-associated growth failure,604302~Rheumatoid arthritis, systemic juvenile,"	"R-HSA-1059683:R-HSA-1059683,R-HSA-110056:R-HSA-110056,R-HSA-112411:R-HSA-112411,R-HSA-2559582:R-HSA-2559582,"
KLK11	kallikrein related peptidase 11(KLK11)	Homo sapiens	"GO:0006508~proteolysis,"	"GO:0005615~extracellular space,GO:0005794~Golgi apparatus,GO:0070062~extracellular exosome,"	"GO:0004252~serine-type endopeptidase activity,GO:0008236~serine-type peptidase activity,"			
LRG1	leucine rich alpha-2-glycoprotein 1(LRG1)	Homo sapiens	"GO:0001938~positive regulation of endothelial cell proliferation,GO:0030511~positive regulation of transforming growth factor beta receptor signaling pathway,GO:0045766~positive regulation of angiogenesis,GO:0050873~brown fat cell differentiation,"	"GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0016020~membrane,GO:0070062~extracellular exosome,"	"GO:0005160~transforming growth factor beta receptor binding,"			
NPPB	natriuretic peptide B(NPPB)	Homo sapiens	"GO:0006182~cGMP biosynthetic process,GO:0007166~cell surface receptor signaling pathway,GO:0007168~receptor guanylyl cyclase signaling pathway,GO:0007589~body fluid secretion,GO:0008217~regulation of blood pressure,GO:0016525~negative regulation of angiogenesis,GO:0030308~negative regulation of cell growth,GO:0035810~positive regulation of urine volume,GO:0035815~positive regulation of renal sodium excretion,GO:0042312~regulation of vasodilation,GO:0043114~regulation of vascular permeability,"	"GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0043234~protein complex,"	"GO:0005102~receptor binding,GO:0005179~hormone activity,GO:0005515~protein binding,GO:0008613~diuretic hormone activity,"	"hsa04022:cGMP-PKG signaling pathway,"		
PSPHP1	phosphoserine phosphatase pseudogene 1(PSPHP1)	Homo sapiens	"GO:0008283~cell proliferation,GO:0016311~dephosphorylation,"		"GO:0004647~phosphoserine phosphatase activity,"			
PLAT	"plasminogen activator, tissue type(PLAT)"	Homo sapiens	"GO:0001666~response to hypoxia,GO:0006464~cellular protein modification process,GO:0006508~proteolysis,GO:0007596~blood coagulation,GO:0014909~smooth muscle cell migration,GO:0031639~plasminogen activation,GO:0042730~fibrinolysis,GO:0045861~negative regulation of proteolysis,GO:0048008~platelet-derived growth factor receptor signaling pathway,"	"GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0009986~cell surface,GO:0030141~secretory granule,GO:0031012~extracellular matrix,GO:0045177~apical part of cell,GO:0070062~extracellular exosome,"	"GO:0001948~glycoprotein binding,GO:0004252~serine-type endopeptidase activity,GO:0005102~receptor binding,GO:0005515~protein binding,GO:0051219~phosphoprotein binding,"	"hsa04610:Complement and coagulation cascades,hsa05202:Transcriptional misregulation in cancer,"	"612348~Hyperfibrinolysis, familial, due to increased release of PLAT,612348~Thrombophilia, familial, due to decreased release of PLAT,"	"R-HSA-186797:R-HSA-186797,R-HSA-75205:R-HSA-75205,"
PRAP1	proline rich acidic protein 1(PRAP1)	Homo sapiens		"GO:0005576~extracellular region,"	"GO:0005515~protein binding,"			
SELE	selectin E(SELE)	Homo sapiens	"GO:0002092~positive regulation of receptor internalization,GO:0002523~leukocyte migration involved in inflammatory response,GO:0006954~inflammatory response,GO:0007155~cell adhesion,GO:0007157~heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,GO:0007159~leukocyte cell-cell adhesion,GO:0007202~activation of phospholipase C activity,GO:0019722~calcium-mediated signaling,GO:0030029~actin filament-based process,GO:0032496~response to lipopolysaccharide,GO:0034612~response to tumor necrosis factor,GO:0050727~regulation of inflammatory response,GO:0050900~leukocyte migration,GO:0050901~leukocyte tethering or rolling,GO:0070555~response to interleukin-1,"	"GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0005901~caveola,GO:0005905~clathrin-coated pit,GO:0016021~integral component of membrane,GO:0030863~cortical cytoskeleton,GO:0045121~membrane raft,GO:0048471~perinuclear region of cytoplasm,"	"GO:0004888~transmembrane signaling receptor activity,GO:0005515~protein binding,GO:0033691~sialic acid binding,GO:0043274~phospholipase binding,GO:0070492~oligosaccharide binding,"	"hsa04514:Cell adhesion molecules (CAMs),hsa04668:TNF signaling pathway,hsa05143:African trypanosomiasis,hsa05144:Malaria,"	"145500~Blood pressure regulation QTL,"	"R-HSA-202733:R-HSA-202733,"
SELPLG	selectin P ligand(SELPLG)	Homo sapiens	"GO:0007155~cell adhesion,GO:0046718~viral entry into host cell,GO:0050900~leukocyte migration,GO:0050902~leukocyte adhesive activation,GO:0071354~cellular response to interleukin-6,"	"GO:0001931~uropod,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,"	"GO:0001618~virus receptor activity,GO:0005102~receptor binding,GO:0005515~protein binding,"	"hsa04514:Cell adhesion molecules (CAMs),hsa05150:Staphylococcus aureus infection,"		"R-HSA-202733:R-HSA-202733,"
SERPINA6	serpin family A member 6(SERPINA6)	Homo sapiens	"GO:0006810~transport,GO:0008211~glucocorticoid metabolic process,GO:0010951~negative regulation of endopeptidase activity,"	"GO:0005615~extracellular space,GO:0070062~extracellular exosome,"	"GO:0004867~serine-type endopeptidase inhibitor activity,GO:0005496~steroid binding,"		"611489~Corticosteroid-binding globulin deficiency,"	
SHBG	sex hormone binding globulin(SHBG)	Homo sapiens		"GO:0005576~extracellular region,GO:0070062~extracellular exosome,"	"GO:0005496~steroid binding,GO:0005497~androgen binding,"			
TF	transferrin(TF)	Homo sapiens	"GO:0001895~retina homeostasis,GO:0002576~platelet degranulation,GO:0006879~cellular iron ion homeostasis,GO:0031647~regulation of protein stability,GO:0033572~transferrin transport,GO:0048260~positive regulation of receptor-mediated endocytosis,GO:0055072~iron ion homeostasis,GO:0071281~cellular response to iron ion,GO:0097460~ferrous iron import into cell,"	"GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005769~early endosome,GO:0005770~late endosome,GO:0005905~clathrin-coated pit,GO:0009925~basal plasma membrane,GO:0009986~cell surface,GO:0010008~endosome membrane,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0016324~apical plasma membrane,GO:0030120~vesicle coat,GO:0030139~endocytic vesicle,GO:0031232~extrinsic component of external side of plasma membrane,GO:0031410~cytoplasmic vesicle,GO:0031982~vesicle,GO:0034774~secretory granule lumen,GO:0045178~basal part of cell,GO:0048471~perinuclear region of cytoplasm,GO:0055037~recycling endosome,GO:0070062~extracellular exosome,GO:0072562~blood microparticle,GO:0097433~dense body,GO:1990712~HFE-transferrin receptor complex,"	"GO:0005515~protein binding,GO:0008198~ferrous iron binding,GO:0008199~ferric iron binding,GO:0015091~ferric iron transmembrane transporter activity,GO:1990459~transferrin receptor binding,"	"hsa04066:HIF-1 signaling pathway,hsa04978:Mineral absorption,"	"209300~Atransferrinemia,"	"R-HSA-114608:R-HSA-114608,R-HSA-917937:R-HSA-917937,R-HSA-917977:R-HSA-917977,"
TNFSF12	tumor necrosis factor superfamily member 12(TNFSF12)	Homo sapiens	"GO:0001525~angiogenesis,GO:0001938~positive regulation of endothelial cell proliferation,GO:0006915~apoptotic process,GO:0006955~immune response,GO:0007165~signal transduction,GO:0030154~cell differentiation,GO:0033209~tumor necrosis factor-mediated signaling pathway,GO:0043542~endothelial cell migration,GO:0045732~positive regulation of protein catabolic process,GO:0045766~positive regulation of angiogenesis,GO:0097190~apoptotic signaling pathway,GO:0097191~extrinsic apoptotic signaling pathway,GO:2001238~positive regulation of extrinsic apoptotic signaling pathway,"	"GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0048471~perinuclear region of cytoplasm,"	"GO:0005102~receptor binding,GO:0005125~cytokine activity,GO:0005164~tumor necrosis factor receptor binding,GO:0005515~protein binding,"	"hsa04060:Cytokine-cytokine receptor interaction,"		"R-HSA-5668541:R-HSA-5668541,R-HSA-5676594:R-HSA-5676594,"
VTN	vitronectin(VTN)	Homo sapiens	"GO:0006898~receptor-mediated endocytosis,GO:0006955~immune response,GO:0007155~cell adhesion,GO:0007160~cell-matrix adhesion,GO:0010811~positive regulation of cell-substrate adhesion,GO:0010951~negative regulation of endopeptidase activity,GO:0014911~positive regulation of smooth muscle cell migration,GO:0030195~negative regulation of blood coagulation,GO:0030198~extracellular matrix organization,GO:0030449~regulation of complement activation,GO:0030949~positive regulation of vascular endothelial growth factor receptor signaling pathway,GO:0032092~positive regulation of protein binding,GO:0033627~cell adhesion mediated by integrin,GO:0035987~endodermal cell differentiation,GO:0048260~positive regulation of receptor-mediated endocytosis,GO:0048709~oligodendrocyte differentiation,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0051258~protein polymerization,GO:0061302~smooth muscle cell-matrix adhesion,GO:0090303~positive regulation of wound healing,GO:0097421~liver regeneration,"	"GO:0005576~extracellular region,GO:0005604~basement membrane,GO:0005615~extracellular space,GO:0005796~Golgi lumen,GO:0031012~extracellular matrix,GO:0048237~rough endoplasmic reticulum lumen,GO:0070062~extracellular exosome,GO:0071062~alphav-beta3 integrin-vitronectin complex,GO:0072562~blood microparticle,"	"GO:0005044~scavenger receptor activity,GO:0005178~integrin binding,GO:0005515~protein binding,GO:0005518~collagen binding,GO:0008201~heparin binding,GO:0030247~polysaccharide binding,GO:0042802~identical protein binding,GO:0050840~extracellular matrix binding,"	"hsa04151:PI3K-Akt signaling pathway,hsa04510:Focal adhesion,hsa04512:ECM-receptor interaction,hsa05205:Proteoglycans in cancer,"		"R-HSA-2129379:R-HSA-2129379,R-HSA-216083:R-HSA-216083,R-HSA-3000170:R-HSA-3000170,R-HSA-3000178:R-HSA-3000178,R-HSA-977606:R-HSA-977606,"
